Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)

NCT00229385 ·Status: COMPLETED ·Phase: NA

A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.

NCT06356389 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan

NCT05359081 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders

NCT00330226 ·Status: UNKNOWN

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

NCT01215383 ·Status: UNKNOWN

Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo

NCT00570063 ·Status: TERMINATED ·Phase: PHASE2

Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2).

NCT03370640 ·Status: COMPLETED ·Phase: PHASE1

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

NCT01602029 ·Status: COMPLETED ·Phase: PHASE2

Adjunctive Vortioxetine in Schizophrenia

NCT02357797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of Pharmacotherapy of Psychotic Depression

NCT00056472 ·Status: COMPLETED ·Phase: PHASE3

Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia

NCT00876304 ·Status: COMPLETED ·Phase: PHASE1

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

NCT04010305 ·Status: COMPLETED ·Phase: PHASE1

An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia

NCT02970929 ·Status: COMPLETED ·Phase: PHASE2

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCT05958875 ·Status: RECRUITING ·Phase: PHASE4

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

NCT00086593 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study Of Schizophrenia in Both Men and Women

NCT00071747 ·Status: COMPLETED ·Phase: PHASE3

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

NCT03526354 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase

NCT04825860 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia

NCT04325737 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia

NCT02205099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

NCT03356639 ·Status: COMPLETED ·Phase: PHASE1

Safety, Blood Levels and Effects of AUT00206

NCT02589262 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

NCT03164876 ·Status: COMPLETED ·Phase: PHASE1

Shared Decision Making for Patients With First-admission Schizophrenia

NCT01869660 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

NCT01234298 ·Status: WITHDRAWN ·Phase: PHASE3